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OBJECTIVE — To validate a low-cost tool for identifying diabetic patients in rural areas of
Latin America.
RESEARCH DESIGN AND METHODS — A regression equation incorporating post-
prandialtimeandarandomplasmaglucosewasusedtoscreen800adultsinHonduras.Patients
with a probability of diabetes of 20% were asked to return for a fasting plasma glucose (FPG).
A random ﬁfth of those with a screener-based probability of diabetes 20% were also asked to
return for follow-up. The gold standard was an FPG 126 mg/dl.
RESULTS — Thescreenerhadverygoodtestcharacteristics(areaunderthereceiveroperating
characteristic curve  0.89). Using the screening criterion of 0.42, the equation had a sensi-
tivity of 74.1% and speciﬁcity of 97.2%.
CONCLUSIONS — This screener is a valid measure of diabetes risk in Honduras and could
be used to identify diabetic patients in poor clinics in Latin America.
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A
s the global prevalence of diabetes
increases,developingcountrieswill
experience 80% of the burden (1).
A recent study (2) found that 7.8% of
adults in the capital city of Honduras had
diabetes and 42% of them were unaware
of their condition.
There is little consensus about the
mostcost-effectivemeansofscreeningfor
diabetes in developing countries (3). The
oral glucose tolerance test is difﬁcult to
implement, and laboratory-based A1C
testing is unavailable in many areas (4).
Screening tools have been developed that
combine risk factor information into an
overall estimate of patients’ probability of
disease(4–8).Modelslimitedtoinforma-
tion about patient demographics, BMI,
andbloodpressureoftenshowonlymod-
erate test speciﬁcity. In contrast, a screen-
ing algorithm that incorporates random
plasma glucose test results and postpran-
dial time has shown excellent predictive
accuracy (4,5). Additional validation is
important to ensure that the instrument
has adequate sensitivity and speciﬁcity in
Latin America, given differences in diet,
body structure, and other risk factors in
the region. The purpose of the current
study was to validate this diabetes-
screening tool among patients seeking
medical care in Honduras.
RESEARCH DESIGN AND
METHODS— The study was con-
ducted in a primary care clinic serving
low-incomepatientsincentralHonduras.
Eight hundred adult patients, who were
not pregnant, did not have a heart attack
in the prior 3 months, and had no diag-
nosis of diabetes were recruited. The
study was approved by our university in-
stitutional review board.
Initial screening
Participants completed a face-to-face in-
terview and a random plasma glucose test
using a ﬁngerstick blood sample and the
Accu-Chek Aviva point-of-care capillary
glucose meter. The survey included ques-
tions regarding sociodemographic and
family history risk factors (9). Blood pres-
sureandBMI(kg/m
2)wererecordedwith
weight, which was measured while the
patient wore light clothing and no shoes.
Postprandial time was recorded as the
numberofhourssincetheparticipantlast
ate or drank anything other than water.
Survey responses and clinical measure-
ments were used to calculate their proba-
bility of diabetes using the following
equation (4): p (diabetes)  1/[1 
exp(X)], where X  10.0382 
0.0331(ageinyears)0.0308(ran-
dom plasma glucose in mg/dl)  0.25 
(self-reported postprandial time assessed
inhours)0.562(iffemale)0.0346
(BMI).
Follow-up fasting glucose test
All participants with an equation-based
probability of diabetes 20% were asked
to return for evaluation at least 24 h after
their initial visit, having fasted for at least
8 h. Every ﬁfth participant with a proba-
bility of diabetes 20% also was asked to
return for follow-up. During follow-up
visits, fasting plasma glucose (FPG) was
measured using 10 l of capillary blood
derived from a ﬁngerstick and the
HemoCue 200 analyzer. Patients were
considered to have diabetes if their FPG
was 126 mg/dl (10). These patients
were referred for further evaluation.
Analysis
To validate the prognostic signiﬁcance of
the screening equation and identify the
optimal cut point for determining a posi-
tive screening test, a maximum-likeli-
hood receiver-operating characteristic
(ROC)curvewasﬁtusingSTATA’sROCFIT
procedure (11). Positive and negative pre-
dictive values were then calculated across a
range of cut points.
We assigned all 800 recruited pa-
tients into two levels of diabetes risk, us-
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diabetesprobabilityandFPGtestresult(if
completed). Within low- and high-risk
groups, we differentiated individuals
whose risk was conﬁrmed based on an
FPG and those whose risk was based
solely on their initial screening. Between
and within groups, we examined the
characteristics of patients associated with
the likelihood of returning for an FPG
test.
RESULTS
Patient recruitment and follow-up
A total of 800 patients participated (266
menand534women).Meanagewas38.5
years, and the average monthly house-
hold income was USD 319. Of the origi-
nal sample, 8.4% were identiﬁed as
having a 20% risk of diabetes and were
asked to return for FPG testing. The re-
maining patients had 20% risk, and of
these 133 (20%) were asked to return for
follow-up. Two-thirds (66.5%) of all pa-
tients who were asked to return for fol-
low-upreturned,withnodifferenceinthe
proportion returning based on their esti-
mated probability of diabetes. Among
high-risk patients, those who failed to re-
turn were more likely to be older, male,
have little formal education, and have
seven or more children.
Test performance
Using FPG 126 mg/dl as the gold stan-
dard, the screener had very good predic-
tive accuracy with an overall area under
the curve (AUC) of 0.89 (Fig. 1). Classiﬁ-
cation accuracy was maximized using a
probability of diabetes of 0.42. Using that
criterion, 74.1% of all patients with dia-
betes conﬁrmed by FPG were correctly
classiﬁed,aswere97.2%ofpatientswith-
out diabetes (a false-positive rate of 3%).
Assuming a diabetes prevalence of 7.4%
(the best estimate based on this sample),
the test had a positive predictive value of
68% and a negative predictive value of
98%.
CONCLUSIONS — In Latin Amer-
ica,diabetesoftengoesundiagnoseduntil
a major health event occurs (1–3,12–14).
A formula-based screening tool that in-
cludes a random plasma glucose, infor-
mation about postprandial time, and
basic information about other risk factors
is a viable approach to identify most pa-
tients with diabetes in Honduras.
Comparisons of the AUC in the cur-
rent study (0.89) with prior studies using
the same screening tool show that the
screener performed at least as well in
Honduras as in other parts of the world
(4,5). However, the cut point for identi-
fying probable diabetes has varied across
studies.Inthecurrentstudy,aprobability
of0.42wasassociatedwithasensitivityof
74.1% and speciﬁcity of 97.2%. In com-
parison, a suggested cut point of 0.2 in
Egypt was associated with a somewhat
lower sensitivity (65%) and roughly
equivalent speciﬁcity of 96% (4). In the
U.S., a cut point of 0.38 was associated
with poorer sensitivity (53%) and speci-
ﬁcity (89%) (5). These differences in cut
points and test performance suggest that
furtherevaluationinLatinAmericawould
beuseful,especiallyinstudiesusingother
diagnostic tests such as the 2-h plasma
glucosetest,oralglucosetolerancetest,or
A1C. Especially since clinical guidelines
recommend repeating FPG on a second
day for diagnosing diabetes, other stud-
ies with different gold standards are
warranted.
High-risk patients who failed to re-
turn for FPG testing had increased travel
distance, lower educational attainment,
and larger family size, suggesting that the
screener may be an effective adjunct to
conﬁrmatory measures such as an FPG,
reachingmorepatientswithdiabetesand,
in particular, those at heightened risk for
poor outcomes. While further validation
in Latin America is important, this
screener should be considered for use
throughout the region.
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